TIL
Instil Bio Inc.
7.20$
+1.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Instil Bio Inc. (TIL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -4.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.3 | -3.3 | -7.2 | -17 | -18 | -32 | -29 | -43 | -55 | -47 | -41 | -37 | -35 | -20 | -14 | -13 | -14 | -11 | -20 | -11 | -4.2 | -15 | -11 | -7.1 | -1.3 | -4.6 | -24 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.4 | 0.7 | 0.8 | 0.9 | 0.9 | 1.1 | 1.9 | 2.1 | 1.8 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | 0.7 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | |
| 0.1 | 0.9 | 0.3 | 0.4 | 2.8 | 5.7 | 8.7 | 8.9 | 7.5 | 8.3 | 8.0 | 6.6 | 4.5 | 4.4 | 4.7 | 4.6 | 4.5 | 4.2 | 4.1 | 4.5 | 3.5 | 1.8 | 1.8 | 1.6 | 1.0 | 1.0 | 5.4 | |
| 0.2 | 5.4 | 0.2 | – | 3.0 | 5.6 | 9.5 | 9.5 | 6.7 | 10.0 | 8.7 | – | 18 | 5.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.6 | 0.5 | -0.2 | -0.4 | 2.0 | -3.1 | 3.4 | 2.2 | -9.7 | 1.1 | 4.7 | -5.6 | -3.8 | -5.4 | 1.2 | -1.1 | 1.8 | -1.0 | -9.3 | -4.1 | 3.6 | -5.0 | 0.7 | 0.1 | 1.3 | -2.1 | 0.1 | |
| 1.0 | 0.3 | 4.3 | 45 | 9.1 | 8.5 | 22 | 18 | 20 | 26 | 25 | 13 | 8.5 | 7.0 | 5.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -1.3 | -0.3 | -4.3 | -45 | -9.1 | -8.5 | -517 | 60 | 78 | -22 | 25 | 33 | 15 | 10 | 2.3 | 14 | 9.2 | 12 | 20 | 13 | 9.6 | -0.4 | 8.4 | 7.8 | -0.3 | 5.3 | 21 | |
| – | – | – | – | -52 | 52 | 0.1 | 0.2 | 0.3 | 0.6 | 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 50 | 50 | 50 | 50 | 14 | – | 4.5 | 4.2 | – | – | – | – | 0.0 | 2.8 | – | – | – | – | – | – | – | |
| 395 | 180 | 0.1 | 133 | 395 | -1.9 | 0.1 | 0.2 | 0.3 | 51 | 15 | 6.2 | 4.5 | 4.2 | -0.6 | 1.0 | 0.0 | 0.0 | 0.2 | 1.6 | 0.2 | 6.7 | 0.4 | 0.0 | 0.0 | 0.0 | 0.4 | |
| -3.3 | 176 | -11 | 71 | 368 | -43 | -546 | 17 | 24 | -19 | -1.3 | 2.1 | -16 | -5.1 | -13 | 1.6 | -5.2 | 1.3 | -0.1 | 4.0 | 5.7 | -8.5 | -1.8 | 0.7 | -1.7 | 0.7 | -2.0 | |
| -3.3 | -3.6 | -12 | -62 | -27 | -41 | -51 | -61 | -75 | -73 | -66 | -50 | -43 | -27 | -20 | -13 | -14 | -11 | -20 | -11 | -4.2 | -15 | -11 | -7.1 | -1.3 | -4.6 | -24 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.